Best practices for detection, assessment and management of suspected immune-mediated liver injury caused by immune checkpoint inhibitors during drug development.
暂无分享，去创建一个
R. Fontana | P. Watkins | H. Bonkovsky | N. Chalasani | J. Freston | M. Patwardhan | N. Pehlivanov | G. Kullak-Ublick | J. Uetrecht | E. Miller | M. Avigan | A. D. Di Bisceglie | M. Harrison | J. Vierling | A. Regev | Hewei Li | K. Price | Stephanie O Omokaro | Syed Asif Haque | A. Kiazand | N. N. Patel | J. Lewis